Kopran share price
You have to be logged in to add this to Watchlist.- ₹206.35(6.50%)May 29, 2026 15:58:32 PM IST
- NSE
- BSE
- Vol : 4.02 M (NSE + BSE)Last 20 day avg : 1.74 M
Kopran is trading 6.50% upper at Rs 206.35 as compared to its last closing price. Kopran has been trading in the price range of 218.90 & 189.30. Kopran has given 28.68% in this year & 15.80% in the last 5 days. Kopran has TTM P/E ratio 20.31 as compared to the sector P/E of 25.42.The company posted a net profit of 18.87 Crores in its last quarter.Listed peers of Kopran include Sun Pharmaceutical Industries (-2.39%), Torrent Pharmaceuticals (-2.42%), Dr Reddy's Laboratories (-1.22%).The Mutual Fund holding in Kopran was at 0.94% in 31 Mar 2024. The MF holding has increased from the last quarter. The FII holding in Kopran was at 0.57% in 31 Mar 2026. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on May 31, 2026, 07:25 PM UTC
- BetaHigh volatility1.35Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.29The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldHigher than industry1.55Annual dividends as a percentage of the stock price.
- P/BLower than historical values1.76The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values36.39Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates undervaluation-18.98The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | Neutral | 1,800.90 | -2.39 | 4,31,933.51 | 37.11 | 5.91 | 0.93 | 0.50 |
| Torrent Pharmaceuticals | Bullish | 4,431.15 | -2.42 | 1,50,004.66 | 74.30 | 18.87 | 0.83 | 17.62 |
| Dr Reddy's Laboratories | Neutral | 1,302.95 | -1.22 | 1,08,746.54 | 19.57 | 3.3 | 0.60 | 2.34 |
| Divi's Laboratories | Neutral | 6,660.20 | -2.02 | 1,76,980.35 | 79.06 | 11.59 | 0.46 | 0.01 |
| Cipla | Neutral | 1,398.50 | -1.39 | 1,12,970.91 | 20.21 | 3.41 | 0.99 | 0.81 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-05-19 | Audited Results & Final Dividend |
| 2026-01-22 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-07-29 | Quarterly Results |
| 2025-05-15 | Audited Results & Final Dividend |
- IndustryBiotechnology & Drugs
- ISININE082A01010
- BSE Code524280
- NSE CodeKOPRAN
Kopran is trading at 206.35 as on Fri May 29 2026 10:28:32. This is 6.50% upper as compared to its previous closing price of 193.75.
The market capitalization of Kopran is 1004.39 Cr as on Fri May 29 2026 10:28:32.
The 52 wk high for Kopran is 212.50 whereas the 52 wk low is 107.00
Kopran can be analyzed on the following key metrics -
- TTM P/E: 20.31
- Sector P/E: 25.42
- Dividend Yield: 1.55%
- D/E ratio: 0.29
Kopran reported a net profit of 25.73 Cr in 2026.
The Mutual Fund Shareholding was 0.94% at the end of 31 Mar 2024.
EQUITY QUICK LINKS
Kopran QUICK LINKS
FROM MARKETS
RELATED LINKS
Quarterly Results
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.